Esomeprazole Magnesium (marketed as Nexium) Information
The U.S. Food and Drug Administration approved Nexium (esomeprazole magnesium) for short-term use in children ages 1-11 years for the treatment of gastroesophageal reflux disease (GERD).
Back
to Top Back to Drug Index
PDF requires the free Adobe Acrobat Reader
Date created: February 28, 2008
|